Wave Life Sciences
108 hedge funds and large institutions have $283M invested in Wave Life Sciences in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 24 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 30
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
2% less funds holding
Funds holding: 110 → 108 (-2)
8.37% less ownership
Funds ownership: 82.38% → 74% (-8.4%)
10% less capital invested
Capital invested by funds: $316M → $283M (-$33.1M)
21% less call options, than puts
Call options by funds: $1.32M | Put options by funds: $1.67M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$8.22M |
| 2 |
D.E. Shaw & Co
New York
|
+$6.65M |
| 3 |
Primecap Management
Pasadena,
California
|
+$5.23M |
| 4 |
BlackRock
New York
|
+$4.79M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
-$7.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.53M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$6.48M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.13M |
| 5 |
PCM
Pinz Capital Management
New York
|
-$4.88M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MAM
126
Meeder Asset Management
Dublin,
Ohio
| – | -$5K | -600 | Closed |
|
127
US Bancorp
Minneapolis,
Minnesota
| – | -$2K | -217 | Closed |
|
|
IA
128
IFP Advisors
Tampa,
Florida
| – | -$319 | -38 | Closed |
|
|
S
129
SignatureFD
Atlanta,
Georgia
| – | +$520 | +62 | New |
|
130
Rockefeller Capital Management
New York
| – | +$688 | +82 | New |
|
WVE Hedge Fund Activity: Q4 2020 in Review
108 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2020, worth a combined $283M — down 10% from $316M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of WVE and 22 opened new positions — a net loss of 2 holders — while 30 trimmed existing stakes and 38 added.
The largest buyer was Nantahala Capital Management, adding an estimated $8.22M. The largest seller was Luminus Management, exiting entirely with an estimated $7.6M sold.
- 108 institutional investors held Wave Life Sciences (WVE) as of Q4 2020, down from 110 in Q3 2020.
- Funds reported $283M of Wave Life Sciences stock for Q4 2020, down 10% quarter-over-quarter.
- 22 funds opened new Wave Life Sciences positions in Q4 2020 and 24 closed out, a net change of -2 holders.
- The largest Wave Life Sciences buyer in Q4 2020 was Nantahala Capital Management, an estimated $8.22M added.
- The largest Wave Life Sciences seller in Q4 2020 was Luminus Management, an estimated $7.6M sold.
Based on aggregated 13F filings for Q4 2020.